Rapha Capital Management

• Media Center News & Press Events & Presentations
• Rapha Capital BioVentures Fund I
• Rapha Capital PE Life Sciences Fund VI, LP
• Exit History Poseida Therapeutics, Inc
• NexImmune, Inc
• Disclaimer
• Portfolio 3DBio Therapeutics angelMD AsclepiX Therapeutics Bellicum Pharmaceuticals ControlRad DELiver Therapeutics Demeetra Agbio FIZE Medical, Ltd IMAGIN Medical K2 Biolabs NexImmune, Inc
• NuMat Technologies, Inc
• Ponce Therapeutics Poseida Therapeutics, Inc
• Sightly Enterprises, Inc
• Rapha Entities Arbor Rapha SPAC Rapha Capital PE Life Sciences Fund V & VI
• Media Center News & Press Events & Presentations

Identifying potentially disruptive biopharmaceutical companies within a sea of less compelling opportunities

Learn More About Rapha Capital

The Rapha Capital Mission is to use our unique abilities to identify at the earliest stage, those companies that we believe will go on to profoundly improve peoples’ lives while building great value, from a sea of seemingly indistinguishable, less compelling, opportunities.

Rapha Capital Management is focused on identifying and growing revolutionary ideas in medicine, healthcare and technology before others can see their value

Rapha Capital Management, LLC, founded in mid-2018, has grown to include 13 managed entities, Rapha Capital Investment I – XIII.

Rapha Capital Latest News

Popular Science Magazine Names 3D Bio Therapeutics “Best of What’s New – 2022” Grand Award Winner in Health for AuriNovo™

Imagin Medical Announces Acquisition of the enCAGE Coil™ Precision Ablation System for Prostate Cancer and a New $7.25M Convertible Note to Finance Its Development

Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma’s Nano-in™ and No-Pass Mimic™ Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin

9511 Collins Avenue, #1403 Surfside, FL 33154 info@raphacap com Rapha Capital Management, LLC is providing this website for informational purposes only Nothing on this website is intended to constitute, or should be deemed to be, financial advisory, legal, tax, accounting or other professional advice to you or any other party; be an opinion of the appropriateness or suitability of any investment; or constitute an offer to sell or solicitation of an offer to buy any security or investment This website and its content (collectively, “Content”) is intended for general informational purposes only and should not be acted upon without first obtaining financial advisory, legal, tax, accounting or other professional advice from your consultant or other professional with respect to your own personal investment objectives, financial circumstances and needs Nothing on the Site shall be considered a recommendation or solicitation to buy or an offer to sell a security to any person in any jurisdiction where such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction Any investment decisions you may make on the basis of any information found on this web site is your sole responsibility Prior to making any investment or hiring any investment manager you should consult with a professional financial advisor, legal and tax advisor to assist in due diligence as may be appropriate and determining the appropriateness of the risk associated with a particular investment In no event shall Rapha Capital Management, LLC be responsible or liable for the correctness of any such material or for any damage or lost opportunities resulting from use of these data